Doctor profile · Federal record
Dr. MHD AL-MARRAWI, MD
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Internal Medicine Physician · Hematology & Oncology Physician · MANSFIELD, OH
- NPI 1588602627
- Accepts Medicare
- 31 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1125 ASPIRA CT
MANSFIELD, OH 44906
(419) 756-2122
fax (419) 756-3530 - Additional location
-
100 Fairfield Dr, UPMC Northwest Cancer Center
Seneca, PA 163462130
(814) 676-7900
fax (814) 676-7887
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- March 7, 2023
- Year of graduation
- 1995 — 31 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (3)
- Ohio #35082422 · Ohio #35.082422 · Pennsylvania #MD421459
- Medicaid
- OH #2424326
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588602627. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,601
Distinct HCPCS
10
Medicare allowed
$178,884
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 2,640 | 17 | $23 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 1,600 | 13 | $22 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 480 | 13 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 370 | 11 | $1 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 267 | 172 | $86 | |
96375 |
Injection of additional new drug or substance into vein | 141 | 27 | $14 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 137 | 17 | $19 | |
96372 |
Injection of drug or substance under skin or into muscle | 132 | 46 | $13 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 120 | 40 | $59 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 92 | 43 | $122 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 209. This provider delivers 32× the peer median.Open Payments
Industry payments received
All-time total
$72
Transactions
3
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $40.45 | |
| Coherus Biosciences Inc. | 1 | $31.75 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
461
Patients
119
Total drug cost
$568,177
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 66 | 25 | $2,464 |
| Acyclovir | Generic | 50 | 12 | $995 |
| Alendronate Sodium | Generic | 44 | 16 | $379 |
| Potassium Chloride | Generic | 36 | 17 | $529 |
| Hydroxyurea | Generic | 35 | 0 | $1,369 |
| Calquence (Acalabrutinib Maleate) | Brand | 31 | 0 | $491,089 |
| Ondansetron Hcl | Generic | 31 | 21 | $802 |
| Anastrozole | Generic | 25 | 0 | $706 |
| Pantoprazole Sodium | Generic | 25 | 12 | $398 |
| Allopurinol | Generic | 22 | 0 | $313 |